Metabolic syndrome as a risk factor for the development of preeclampsia in pregnant women
The main task of modern obstetrics, along with reducing maternal and perinatal mortality, is improving the health of the expectant mother, fetus and newborn. In recent decades, one of the leading topics that concern doctors all over the world, including obstetricians and gynecologists, is metabolic disorders, which in turn is the starting point for the development of complications from the second half of pregnancy. Preeclampsia is a complication of pregnancy characterized by a profound disorder of the functions of vital organs and systems of the expectant mother. Undoubtedly, preeclampsia, which from a pathogenetic point of view is one of the clinical manifestations of the “great obstetric syndrome” and is a multisystem pathological condition, continues to be an urgent problem of modern obstetrics. It is preeclampsia that makes up a significant share in the structure of maternal and perinatal morbidity and mortality. Perinatal mortality in severe forms of preeclampsia is 18–30%, and perinatal morbidity is 64–78%.